Skip to main content
. 2014 Nov 27;7:537. doi: 10.1186/s13071-014-0537-z

Table 2.

Cytotoxicity and anti-MAYV activity of EtOAc, n-BuOH and EtOAc-Pp fractions

Substance CC 50 (μg/mL) a CC 90 (μg/mL) a IC 50 (μg/mL) b IC 90 (μg/mL) b SI c RP d
n-BuOH 2614 ± 366 821 ± 115 7,1 ± 1,0 40,9 ± 5,7 20 10
EtOAc 457,7 ± 9,5 176,1 ± 3,5 8,2 ± 0,2 89,1 ± 4,4 2 1
EtOAc-Pp 324,1 ± 6,5 154,7 ± 3,1 2,5 ± 0,1 4,7 ± 0,3 33 16,5
ribavirin 523,1 ± 42,5 215,4 ± 6,2 62,3 ± 4,4 112,4 ± 8,2 2 nd

a50% and 90% cytotoxic concentration.

b50% and 90% inhibitory concentration of viral replication.

cSelectivity Index = standard IC90/substance IC90.

dRelative Potency = ratio between ribavirin (reference substance) IC90 and the tested substance’s IC90.

nd – Not determined.